05/24/2013 8:37 AM
Covidien Board of Directors Approves Separation of Pharmaceuticals Business and Declares Dividend of Mallinckrodt Ordinary Shares
DUBLIN--(BUSINESS WIRE)--May 24, 2013--
Covidien
plc (NYSE: COV), a leading global provider of healthcare products, today
announced that its board of directors has approved the separation of the
Pharmaceuticals business from the rest of Covidien The separation will
...
05/24/2013 8:38 AM
Covidien and Mallinckrodt to Present at Deutsche Bank Conference
MANSFIELD, Mass--(BUSINESS WIRE)--May 23, 2013--
Covidien
(NYSE: COV), a leading global provider of healthcare products, will
present at the Deutsche Bank 38th Annual Health Care Conference in
Boston on Wednesday and Thursday, May 29 and 30, 2013
José E Almeid...